Back

Mineralocorticoid receptor antagonists for atrial fibrillation prevention: effective solution or empty promise?

European Heart Journal

17 October 2024
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY HEART FAILURE Chronic Heart Failure Atrial Fibrillation (AF)

Contributors

Alireza Oraii
Alireza Oraii

Author

Jeff S Healey
Jeff S Healey

Author

William F McIntyre
William F McIntyre

Author

Population Health Research Institute Hamilton , Canada

You may be interested in
thumbnail
Congress Presentation
Mineralocorticoid receptor antagonists as preventive therapy for atrial fibrillation
30 August 2026
thumbnail
Congress Presentation
The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling
3 September 2019
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
Mineralocorticoid receptor antagonists after acute myocardial infarction in patients with mild to moderately reduced ejection fraction
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources